U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H23N3O5S.ClH
Molecular Weight 429.918
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CGS-27023A ANHYDROUS

SMILES

Cl.COC1=CC=C(C=C1)S(=O)(=O)N(CC2=CN=CC=C2)[C@H](C(C)C)C(=O)NO

InChI

InChIKey=ZVYIZSNCEAHMCF-UNTBIKODSA-N
InChI=1S/C18H23N3O5S.ClH/c1-13(2)17(18(22)20-23)21(12-14-5-4-10-19-11-14)27(24,25)16-8-6-15(26-3)7-9-16;/h4-11,13,17,23H,12H2,1-3H3,(H,20,22);1H/t17-;/m1./s1

HIDE SMILES / InChI

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
1.5 nM [IC50]
4.8 nM [IC50]
7.7 nM [IC50]
16.0 nM [IC50]
23.0 nM [IC50]
Name Type Language
MMI-270B ANHYDROUS
Preferred Name English
CGS-27023A ANHYDROUS
Code English
BUTANAMIDE, N-HYDROXY-2-(((4-METHOXYPHENYL)SULFONYL)(3-PYRIDINYLMETHYL)AMINO)-3-METHYL-, HYDROCHLORIDE (1:1), (2R)-
Systematic Name English
MMI270B ANHYDROUS
Code English
Code System Code Type Description
DRUG BANK
DBSALT002934
Created by admin on Tue Apr 01 21:11:00 GMT 2025 , Edited by admin on Tue Apr 01 21:11:00 GMT 2025
PRIMARY
CAS
169799-04-6
Created by admin on Tue Apr 01 21:11:00 GMT 2025 , Edited by admin on Tue Apr 01 21:11:00 GMT 2025
PRIMARY
PUBCHEM
9888897
Created by admin on Tue Apr 01 21:11:00 GMT 2025 , Edited by admin on Tue Apr 01 21:11:00 GMT 2025
PRIMARY
FDA UNII
BS0VY94Q43
Created by admin on Tue Apr 01 21:11:00 GMT 2025 , Edited by admin on Tue Apr 01 21:11:00 GMT 2025
PRIMARY